PHARMAID

PHARMAIDS PHARMACEUTICALS

Small Cap BSE: 524572 NSE: PHARMAID
₹17.97
-0.43 (-2.34%)
As on 01 December, 2022 | 00:07

Pharmaids Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in PHARMAIDS PHARMACEUTICALS

Start SIP

Pharmaids Pharmaceuticals Share Price

Pharmaids Pharmaceuticals Share Returns

  • Over 1 Month 27.27%
  • Over 3 Month 35.52%
  • Over 6 Month 50.76%
  • Over 1 Year 26.11%

Pharmaids Pharmaceuticals Key Statistics

Pharmaids Pharmaceuticals Investment Rating

  • Master Rating:
  • Pharmaids Pharms. has an operating revenue of Rs. 3.94 Cr. on a trailing 12-month basis. An annual revenue de-growth of -54% needs improvement, Pre-tax margin of 4% needs improvement, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It has recently broken out of a base in its weekly chart and is trading around 21% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 6 which is a POOR score indicating inconsistency in earnings, a RS Rating of 78 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Pharmaids Pharmaceuticals Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 0001122
Operating Expenses Qtr Cr 1001022
Operating Profit Qtr Cr -1000000
Depreciation Qtr Cr 0000000
Interest Qtr Cr 0000000
Tax Qtr Cr 0000000
Net Profit Qtr Cr -1000000

Pharmaids Pharmaceuticals Technicals

EMA & SMA

Current Price
17.97
-0.43 (-2.34%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 14.68
  • 50 Day
  • 13.96
  • 100 Day
  • 13.55
  • 200 Day
  • 13.07
  • 20 Day
  • 14.09
  • 50 Day
  • 13.83
  • 100 Day
  • 13.21
  • 200 Day
  • 13.04

Pharmaids Pharmaceuticals Resistance and Support

PIVOT
₹17.99
Resistance
First Resistance 19.76
Second Resistance 21.12
Third Resistance 22.89
RSI 75.81
MFI 95.52
MACD Single Line 0.31
MACD 0.88
Support
First Resistance 16.63
Second Resistance 14.86
Third Resistance 13.5

Pharmaids Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 97,874 8,310,481 84.91
Week 109,900 8,112,833 73.82
1 Month 32,866 2,480,426 75.47
6 Month 28,174 2,522,713 89.54

Pharmaids Pharmaceuticals Result Highlights

Pharmaids Pharmaceuticals Synopsis

BSE-Medical-Diversified

Pharmaids Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 3.94 Cr. and Equity Capital is Rs. 10.27 Cr. for the Year ended 31/03/2022. Pharmaids Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 01/03/1989 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L52520TG1989PLC009679 and registration number is 009679.
Market Cap 19
Sales 1
Shares in Float 0.81
No of funds
Yield
Book Value 2.13
U/D Vol ratio 3
LTDebt / Equity
Alpha 0.15
Beta 0.65

Pharmaids Pharmaceuticals

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 20.97%20.7%35.44%
Individual Investors 74.19%78.73%63.98%
Others 4.84%0.57%0.58%

Pharmaids Pharmaceuticals Management

Name Designation
Mrs. S Padmaja Kalyani Executive Director
Mr. S Vishwa Prasad Executive Director
Mr. Sadhanala Venkata Rao Non Exe.Non Ind.Director
Mr. Mopperthy Sudheer Independent Director
Mr. Veerareddy Vallapureddy Independent Director
Dr. Vyasmurti Madhavrao Shingatgeri Independent Director

Pharmaids Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Pharmaids Pharmaceuticals Corporate Action

Date Purpose Remarks
2022-11-09 Quarterly Results
2022-10-13 To cconsider issue of Warrants
2022-07-22 Quarterly Results & A.G.M.
2022-05-21 Audited Results
2022-01-28 Quarterly Results

Pharmaids Pharmaceuticals FAQs

What is Share Price of Pharmaids Pharmaceuticals ?

Pharmaids Pharmaceuticals share price is ₹17 As on 30 November, 2022 | 23:53

What is the Market Cap of Pharmaids Pharmaceuticals ?

The Market Cap of Pharmaids Pharmaceuticals is ₹18.5 Cr As on 30 November, 2022 | 23:53

What is the P/E ratio of Pharmaids Pharmaceuticals ?

The P/E ratio of Pharmaids Pharmaceuticals is -27.9 As on 30 November, 2022 | 23:53

What is the PB ratio of Pharmaids Pharmaceuticals ?

The PB ratio of Pharmaids Pharmaceuticals is 2.1 As on 30 November, 2022 | 23:53

Q2FY23